Cargando…
Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder
Autism spectrum disorder (ASD) is a group of developmental disabilities, the aetiology of which remains elusive. The endocannabinoid (eCB) system modulates neurotransmission and neuronal plasticity. Evidence points to the involvement of this neuromodulatory system in the pathophysiology of ASD. We i...
Autores principales: | Zou, Mingyang, Liu, Yu, Xie, Shu, Wang, Luxi, Li, Dexin, Li, Ling, Wang, Feng, Zhang, Yujue, Xia, Wei, Sun, Caihong, Wu, Lijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061688/ https://www.ncbi.nlm.nih.gov/pubmed/33529552 http://dx.doi.org/10.1098/rsob.200306 |
Ejemplares similares
-
The relationship between 2019-nCoV and psychological distress among parents of children with autism spectrum disorder
por: Wang, Luxi, et al.
Publicado: (2021) -
Attention Deficit/Hyperactivity Disorder Symptoms Impair Adaptive and Social Function in Children With Autism Spectrum Disorder
por: Liu, Yu, et al.
Publicado: (2021) -
Perspectives on the Role of Endocannabinoids in Autism Spectrum Disorders
por: Yeh, Mason L., et al.
Publicado: (2017) -
Prenatal Folic Acid Supplements and Offspring’s Autism Spectrum Disorder: A Meta-analysis and Meta-regression
por: Liu, Xian, et al.
Publicado: (2021) -
FADS1-FADS2 and ELOVL2 gene polymorphisms in susceptibility to autism spectrum disorders in Chinese children
por: Sun, Caihong, et al.
Publicado: (2018)